{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:14:42Z","timestamp":1790374482084,"version":"4.1.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.00530","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:18:30Z","timestamp":1521677910000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":118,"title":["Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo"],"prefix":"10.3389","volume":"9","author":[{"given":"Yinhui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.18295\/squmj.2016.16.04.002","article-title":"Statin-associated muscle adverse events: update for clinicians.","volume":"16","author":"Al-Mohaissen","year":"2016","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1874192401408010055","article-title":"Comparative effect of atorvastatin and rosuvastatin on 25-hydroxy-vitamin D levels in non-diabetic patients with dyslipidaemia: a prospective randomized open-label pilot study.","volume":"8","author":"Anagnostis","year":"2014","journal-title":"Open Cardiovasc. Med. J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1185\/030079902125000787","article-title":"Treatment with atorvastatin to the National Cholesterol Educational Program goal versus \u2018usual\u2019 care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.","volume":"18","author":"Athyros","year":"2002","journal-title":"Curr. Med. Res. Opin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1348\/000711006X171970","article-title":"Comparing the squared multiple correlation coefficients of non-nested models: an examination of confidence intervals and hypothesis testing.","author":"Azen","year":"2008","journal-title":"Br. J. Math. Stat. Psychol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1073\/pnas.0605374104","article-title":"Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.","volume":"104","author":"Backhed","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B6","first-page":"185","article-title":"The fecal microbial population in the irritable bowel syndrome.","volume":"5","author":"Balsari","year":"1982","journal-title":"Microbiologica"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.biochi.2015.06.020","article-title":"Metabolic endotoxemia with obesity: is it real and is it relevant?","volume":"124","author":"Boutagy","year":"2016","journal-title":"Biochimie"},{"key":"B8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.coph.2009.06.016","article-title":"Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.","volume":"9","author":"Cani","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3945\/ajcn.2009.28095","article-title":"Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal.","volume":"90","author":"Cani","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data.","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat. Methods"},{"key":"B11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/1755-5922.12214","article-title":"Safety of atorvastatin in Asian patients within clinical trials.","volume":"34","author":"Chan","year":"2016","journal-title":"Cardiovasc. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4014\/jmb.1512.12018","article-title":"Triglyceride-lowering effects of two probiotics, Lactobacillus plantarum KY1032 and Lactobacillus curvatus HY7601, in a rat model of high-fat diet-induced hypertriglyceridemia.","volume":"26","author":"Choi","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"D294","DOI":"10.1093\/nar\/gki038","article-title":"The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis.","volume":"33","author":"Cole","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-015-0116-0","article-title":"Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia.","volume":"14","author":"Ding","year":"2015","journal-title":"Lipids Health Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jff.2016.06.025","article-title":"Oat products modulate the gut microbiota and produce anti-obesity effects in obese rats.","volume":"25","author":"Dong","year":"2016","journal-title":"J. Funct. Foods"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","article-title":"UCHIME improves sensitivity and speed of chimera detection.","volume":"27","author":"Edgar","year":"2011","journal-title":"Bioinformatics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00387","article-title":"Significance of microbiota in obesity and metabolic diseases and the modulatory potential by medicinal plant and food ingredients.","volume":"8","author":"Eid","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063388","article-title":"Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis.","volume":"8","author":"Endo","year":"2013","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrgastro.2016.14","article-title":"Gut microbiota: microbes offer engineering strategies to combat cancer.","volume":"13","author":"Erdman","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/CIRCRESAHA.115.306807","article-title":"The gut microbiome contributes to a substantial proportion of the variation in blood lipids.","volume":"117","author":"Fu","year":"2015","journal-title":"Circ. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/nutrit\/nuv039","article-title":"Potential role of the intestinal microbiota in programming health and disease.","author":"Goulet","year":"2015","journal-title":"Nutr. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1101\/gr.112730.110","article-title":"Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons.","volume":"21","author":"Haas","year":"2011","journal-title":"Genome Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.bbadis.2016.06.006","article-title":"Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways.","volume":"1862","author":"He","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/gut.30.8.1087","article-title":"Evolution of the caecal epithelial barrier during Clostridium difficile infection in the mouse.","volume":"30","author":"Heyman","year":"1989","journal-title":"Gut"},{"key":"B25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome.","volume":"486","year":"2012","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1177\/2047487315598710","article-title":"Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: results from the VOYAGER meta-analysis.","volume":"23","author":"Karlson","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrendo.2015.218","article-title":"The role of the intestinal microbiota in type 1 diabetes mellitus.","volume":"12","author":"Knip","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/1060028016675352","article-title":"Clinical pharmacist patient-safety initiative to reduce against-label prescribing of statins with cyclosporine.","volume":"51","author":"Lamprecht","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrmicro1978","article-title":"Worlds within worlds: evolution of the vertebrate gut microbiota.","volume":"6","author":"Ley","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cell.2006.02.017","article-title":"Ecological and evolutionary forces shaping microbial diversity in the human intestine.","volume":"124","author":"Ley","year":"2006","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota.","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00905","article-title":"Modulation of the gut microbiota by krill oil in mice fed a high-sugar high-fat diet.","volume":"8","author":"Lu","year":"2017","journal-title":"Front. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","article-title":"FLASH: fast length adjustment of short reads to improve genome assemblies.","volume":"27","author":"Magoc","year":"2011","journal-title":"Bioinformatics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/msb4100153","article-title":"A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model.","volume":"3","author":"Martin","year":"2007","journal-title":"Mol. Syst. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/j.1572-0241.2008.01869.x","article-title":"Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.","volume":"103","author":"Parkes","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).","volume":"33","author":"Perk","year":"2012","journal-title":"Eur. Heart J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2174\/15701611113116660166","article-title":"Lipoproteins, stroke and statins.","volume":"13","author":"Pisciotta","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes.","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3305\/nh.2013.28.3.6601","article-title":"Progress in the knowledge of the intestinal human microbiota.","volume":"28","author":"Robles-Alonso","year":"2013","journal-title":"Nutr. Hosp."},{"key":"B41","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","article-title":"Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities.","volume":"75","author":"Schloss","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation.","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1021\/jf902107d","article-title":"Interaction between phenolics and gut microbiota: role in human health.","volume":"57","author":"Selma","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","article-title":"Intestinal microbiota in functional bowel disorders: a Rome foundation report.","volume":"62","author":"Simren","year":"2013","journal-title":"Gut"},{"key":"B45","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/1574-6941.12148","article-title":"454 pyrosequencing analyses of bacterial and archaeal richness in 21 full-scale biogas digesters.","volume":"85","author":"Sundberg","year":"2013","journal-title":"FEMS Microbiol. Ecol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009217.pub2","article-title":"Statins for the primary prevention of cardiovascular disease.","volume":"1","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/srep32002","article-title":"Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease.","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3168\/jds.2011-4768","article-title":"Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet.","volume":"95","author":"Wang","year":"2012","journal-title":"J. Dairy Sci."},{"key":"B49","article-title":"Comparative study of effects and safety of atorvastatin and lovastatin on aged patients with hyperlipidemia.","volume":"33","author":"Wang","year":"2011","journal-title":"J. Shandong Med. Coll."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117851","article-title":"Induction of peroxisomes by butyrate-producing probiotics.","volume":"10","author":"Weng","year":"2015","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MCO.0000000000000044","article-title":"Gut microbiota and allergic disease: new findings.","volume":"17","author":"West","year":"2014","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1053\/j.gastro.2010.08.049","article-title":"A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.","volume":"139","author":"Willing","year":"2010","journal-title":"Gastroenterology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/1747493016670175","article-title":"Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: a population-based study.","volume":"12","author":"Yeramaneni","year":"2017","journal-title":"Int. J. Stroke"},{"key":"B54","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins. - Basic research and clinical perspectives.","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ. J."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00530\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:18:33Z","timestamp":1521677913000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2018.00530\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":54,"alternative-id":["10.3389\/fmicb.2018.00530"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.00530","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"article-number":"530"}}